Serina Therapeutics CEO Michael West's 2019 pay falls 24% to $1M

Serina Therapeutics reports 2019 executive compensation

By ExecPay News

Published: November 24, 2020

Serina Therapeutics reported fiscal year 2019 executive compensation information on November 24, 2020.
In 2019, four executives at Serina Therapeutics received on average a compensation package of $496K, a 31% decrease compared to previous year.
Average pay of disclosed executives at Serina Therapeutics
Michael D. West, Chief Executive Officer, received $1M in total, which decreased by 37% compared to 2018. 52% of West's compensation, or $543K, was in salary. West also received $485K in option awards and $14K in other compensation.
Nafees Malik, Chief Operating Officer, received a compensation package of $519K, which decreased by 34% compared to previous year. 54% of the compensation package, or $280K, was in salary.
Hal Sternberg, Vice President, Research, earned $329K in 2019, a 11% increase compared to previous year.
Andrea E. Park, Chief Financial Officer, received $94K in 2019.

Related executives

Michael West

Serina Therapeutics

Chief Executive Officer

Hal Sternberg

Serina Therapeutics

Vice President, Research

Nafees Malik

Serina Therapeutics

Chief Operating Officer

Andrea Park

Serina Therapeutics

Chief Financial Officer

You may also like

Source: SEC filing on November 24, 2020.